# Baxter Deutschland GmbH – FDA Inspection, May 28, 2025

Source: https://www.keypedia.com/records/fda_inspections/baxter-deutschland-gmbh/ab2bc592-2030-4c1b-9bea-829ff0a34dbd
Source feed: FDA_Inspections

> FDA inspection 1288760 of Baxter Deutschland GmbH, May 28, 2025. Classification: Voluntary Action Indicated (VAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1288760
- Company Name: Baxter Deutschland GmbH
- Inspection Date: 2025-05-28
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1193847 - 2022-11-11](https://www.keypedia.com/records/fda_inspections/baxter-deutschland-gmbh/3a7b7a03-3f8a-45ee-a1e1-ad8c1db5f380)
- FDA Inspection 1060487 - 2018-06-14
- FDA Inspection 957912 - 2016-01-22
- FDA Inspection 746997 - 2011-08-26

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/mra-v-millarw/ea28ecad-65ef-4cbe-9f4b-fa460dcef90f)

Company: https://www.keypedia.com/companies/baxter-deutschland-gmbh/91ec8f78-8f1e-4966-bd89-d4e4aaf6eb76

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c